Phuturdex › Diseases › Breast neoplasm
Drugs in development · updated 30 October 2026
Breast neoplasm: drugs in development
As of 30 October 2026 there are 1,059 active clinical trials (recruiting or ongoing, phases I–III) on 593 drugs for breast neoplasm. 383 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Experimental drugs
Not yet approved by the US FDA for any indication.
Sorted by most advanced phase and number of active trials. Showing 40 of 383 drugs.
Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| FulvestrantCligavyx®, Faslodex® | II–III | 129 | NCT04191499 |
| TrastuzumabHerceptin, tratuzumab | II–III | 108 | NCT07366840 |
| Letrozoleoral Femara | III | 101 | NCT07894328 |
| PaclitaxelTaxol, Paxlitaxel | II–III | 101 | NCT06926868 |
| PertuzumabPerjeta, Poherdy® | II–III | 85 | NCT07294508 |
| PembrolizumabKEYTRUDA, MK-3475 | III | 83 | NCT02954874 |
| CapecitabineXeloda, Capectitabine Tablets | II–III | 81 | NCT06926868 |
| CarboplatinCarboplatine, Paraplatin | II–III | 76 | NCT06926868 |
| CyclophosphamideCyclophosphamid, Cytoxan | II–III | 73 | NCT05889390 |
| AnastrozoleAnastrozol, Anastrazole | III | 57 | NCT04134598 |
| PalbociclibPabociclib, Palbocicilib | II–III | 56 | NCT04191499 |
| AbemaciclibLY2835219, Verzenio® | III | 52 | NCT05696626 |
| DocetaxelTaxotere, Beizray® | II–III | 50 | NCT02641847 |
| ExemestaneAromasin® | III | 48 | NCT04134598 |
| TamoxifenSoltamox®, Nolvadex® | III | 48 | NCT04134598 |
Sorted by most advanced phase and number of active trials. Showing 15 of 210 drugs.
All 593 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Triple-negative breast neoplasm 334 drugs
- Non-small-cell lung carcinoma 726 drugs
- Head and neck squamous cell carcinoma 321 drugs
- Ovarian neoplasm 411 drugs
- Colorectal neoplasm 534 drugs
- Melanoma 352 drugs
- Uterine cervix neoplasm 224 drugs
- Stomach neoplasm 340 drugs
- Metastasis 493 drugs
- Renal cell carcinoma 228 drugs
- Endometrial neoplasm 298 drugs
- Neoplasm 671 drugs
Broader categories
- Skin and connective tissue diseases 3 drugs
- Skin disease 34 drugs
- Breast disease 21 drugs
- Neoplasm 671 drugs
- Urogenital Diseases 16 drugs
- Genital Diseases 7 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D001943 “Breast Neoplasms”.